长沙招聘

1、负责成本、费用方面凭证的编制，严格将各项费用归集到应属的各部门。严格按照新企业会计准则，规范费用业务的帐务处理工作。 

2、审核工厂或研发各部门提交的相关的成本归集到应属的项目，编制相关凭证。 

3、审核产品销售合同、结算单、出库单和销售发票，编制相应凭证。 

4、负责销售发票的开具。 

5、编制客户科目余额表、帐龄分析表等，季度计提坏帐准备及凭证的编制。 

6、负责各客户往来款项的对帐并加强欠款的催收工作。 

任职条件： 

1、全日制本科及以上学历，财务会计相关专业； 

2、1年以上制药行业相关经验，熟悉相关财税法律法规； 

3、工作认真负责、正直诚信、积极主动，有责任心。 

百奥泰生物制药股份有限公司（股票代码：688177）秉承“创新只为生命”的理念，致力于开发新一代创新药和生物类似药，用于治疗肿瘤、自身免疫性疾病、心血管疾病以及其它危及人类生命或健康的重大疾病。公司已推动五款候选药物进入后期临床试验，其中格乐立（阿达木单抗）已在中国获批用于治疗类风湿关节炎、强直性脊柱炎、银屑病、克罗恩病和葡萄膜炎。此外，公司另有多款主攻肿瘤和自身免疫性疾病的候选药物处于不同的临床开发阶段。公司始终以患者的福祉作为首要核心价值，通过创新研发为患者提供安全、有效、可负担的优质药物，以满足亟待解决的治疗需求。欲了解更多信息，请访问公司官网或关注我们的微信公众号“百奥泰”。
Bio-Thera？Solutions, Ltd.a leading commercial-stage biopharmaceutical company in Guangzhou, China, is dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular diseases, and other serious unmet medical needs, as well as biosimilars for existing branded biologics to treat a range of cancer and autoimmune diseases. As a leader in next-generation antibody discovery and engineering, the company has advanced five candidates into late stage clinical trials, one of which, QLETLI, a biosimilar to？Humira？(adalimumab), is available to patients with rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis,？Crohn's disease or uveitis in China. In addition, the company has multiple candidates in early clinical trials and IND-enabling studies, focusing on innovative targets in immuno-oncology and autoimmune diseases.